The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Traces of bacteria inside brain tumors may affect tumor behavior
Gut-Brain Axis

Traces of bacteria inside brain tumors may affect tumor behavior

NOV 24, 2025
Whitepaper: Oral Drug Delivery of Live Biotherapeutics: From Development to Clinical Trial with EUDRACAP® Select
Clinical & Manufacturing

Whitepaper: Oral Drug Delivery of Live Biotherapeutics: From Development to Clinical Trial with EUDRACAP® Select

NOV 19, 2025
Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
Clinical & Manufacturing

Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study

NOV 17, 2025
The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
Editor's Choice

The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies

NOV 12, 2025
Ferring Presents New Data Analyses for REBYOTA®
Infectious Disease & AMR

Ferring Presents New Data Analyses for REBYOTA®

NOV 4, 2025
Seres Therapeutics Receives Award of up to $3.6M from Carb-X to Develop Liquid Formulation of Ser-155
Finance

Seres Therapeutics Receives Award of up to $3.6M from Carb-X to Develop Liquid Formulation of Ser-155

OCT 31, 2025
Concerto Biosciences Announces Positive Topline Results from Phase 1b Clinical Trial of ENS-002 in Patients with Atopic Dermatitis
Clinical & Manufacturing

Concerto Biosciences Announces Positive Topline Results from Phase 1b Clinical Trial of ENS-002 in Patients with Atopic Dermatitis

OCT 29, 2025
Scientists develop a way to track donor bacteria after fecal microbiota transplants
Pharma & Human Health

Scientists develop a way to track donor bacteria after fecal microbiota transplants

OCT 27, 2025
Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome
Gastrointestinal

Discovery of hundreds of new human gut viruses provides a new approach to studying the gut microbiome

OCT 17, 2025
Phagos Raises €25m Series A
Animal Health

Phagos Raises €25m Series A

OCT 10, 2025
New collaborations emerge at Gut-Immune-Brain Axis (GIBA) Network+ launch event
Gut-Brain Axis

New collaborations emerge at Gut-Immune-Brain Axis (GIBA) Network+ launch event

OCT 8, 2025